Official Publications TME Pharma N.V.

Equities

Real-time Euronext Paris Other stock markets 06:37:31 2024-05-23 am EDT			5-day change	1st Jan Change
0.2425 ^EUR	-0.82%		+1.04%	+5.43%

Apr. 25	TME Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 23	TME Pharma N.V. Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two-Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer	CI

Extraordinary general shareholder meeting	22-05-15	CO
Extraordinary general shareholder meeting	22-05-15	CO
Extraordinary general shareholder meeting	22-05-15	CO
Annual Report	22-04-21	CO
Annual results	22-04-21	CO
Annual results	22-04-21	CO
Annual results	22-04-21	CO
Minutes of the general assembly	21-12-14	CO
Minutes of the general assembly	21-12-14	CO
Minutes of the general assembly	21-12-14	CO
Half-year report	21-10-21	CO
1st-half-year results	21-10-21	CO
1st-half-year results	21-10-21	CO
1st-half-year results	21-10-21	CO
Changes in management and corporate officers	21-06-23	CO
Changes in management and corporate officers	21-06-23	CO
Changes in management and corporate officers	21-06-23	CO
Changes in management and corporate officers	21-02-07	CO
Changes in management and corporate officers	21-02-07	CO
Changes in management and corporate officers	21-02-07	CO
Changes in management and corporate officers	21-01-31	CO
Changes in management and corporate officers	21-01-31	CO
Changes in management and corporate officers	21-01-31	CO
Admission of new securities	21-01-25	CO
Admission of new securities	21-01-25	CO